These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15612366)

  • 1. The bone cell biology of osteogenesis imperfecta.
    Fedarko NS; Vetter U; Robey PG
    Connect Tissue Res; 1995; 31(4):269-73. PubMed ID: 15612366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts.
    Fedarko NS; Sponseller PD; Shapiro JR
    J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta.
    Fedarko NS; Moerike M; Brenner R; Robey PG; Vetter U
    J Bone Miner Res; 1992 Aug; 7(8):921-30. PubMed ID: 1442206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta.
    Fedarko NS; Robey PG; Vetter UK
    J Bone Miner Res; 1995 Jul; 10(7):1122-9. PubMed ID: 7484289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.
    Fratzl-Zelman N; Barnes AM; Weis M; Carter E; Hefferan TE; Perino G; Chang W; Smith PA; Roschger P; Klaushofer K; Glorieux FH; Eyre DR; Raggio C; Rauch F; Marini JC
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3516-25. PubMed ID: 27383115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
    Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone cell defects in osteogenesis imperfecta.
    Vignery A
    Connect Tissue Res; 1995; 31(4):275-8. PubMed ID: 15612367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
    Vetter U; Fisher LW; Mintz KP; Kopp JB; Tuross N; Termine JD; Robey PG
    J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.
    Mähr M; Blouin S; Behanova M; Misof BM; Glorieux FH; Zwerina J; Rauch F; Hartmann MA; Fratzl-Zelman N
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cell surface expression of receptors for transforming growth factor-beta on osteoblasts from patients with Osteogenesis imperfecta.
    Gebken J; Brenner R; Feydt A; Notbohm H; Brinckmann J; Müller PK; Bätge B
    Pathobiology; 2000; 68(3):106-12. PubMed ID: 11174067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OIM and related animal models of osteogenesis imperfecta.
    Shapiro JR; Mcbride DJ; Fedarko NS
    Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.
    Gioia R; Panaroni C; Besio R; Palladini G; Merlini G; Giansanti V; Scovassi IA; Villani S; Villa I; Villa A; Vezzoni P; Tenni R; Rossi A; Marini JC; Forlino A
    Stem Cells; 2012 Jul; 30(7):1465-76. PubMed ID: 22511244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen transport and related pathways in Osteogenesis Imperfecta.
    Claeys L; Storoni S; Eekhoff M; Elting M; Wisse L; Pals G; Bravenboer N; Maugeri A; Micha D
    Hum Genet; 2021 Aug; 140(8):1121-1141. PubMed ID: 34169326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic phenotype in the mouse model of osteogenesis imperfecta.
    Boraschi-Diaz I; Tauer JT; El-Rifai O; Guillemette D; Lefebvre G; Rauch F; Ferron M; Komarova SV
    J Endocrinol; 2017 Sep; 234(3):279-289. PubMed ID: 28716975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective association between collagen fibrils and proteoglycans in fragile bone of osteogenesis imperfecta.
    Nogami H; Oohira A
    Clin Orthop Relat Res; 1988 Jul; (232):284-91. PubMed ID: 3383494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.
    Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P
    Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
    Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
    Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in non-type I collagen biomarkers in osteogenesis imperfecta.
    Nicol L; Morar P; Wang Y; Henriksen K; Sun S; Karsdal M; Smith R; Nagamani SCS; Shapiro J; Lee B; Orwoll E
    Bone; 2019 Mar; 120():70-74. PubMed ID: 30290234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.